Is Crossject SA halal to invest in?

According to Musaffa's Shariah screening methodology, Crossject SA (ALCJ.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Crossject SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Crossject SA using these criteria to determine its compliance status.

Can Muslims buy shares of Crossject SA?

Muslim investors may consider investing in Crossject SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Crossject SA classified as HALAL?

Musaffa determines the Shariah status of Crossject SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Crossject SA updated?

The Shariah compliance status of Crossject SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Crossject SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Crossject SA?

You can check the latest Shariah compliance status of Crossject SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Crossject SA ALCJ.PA

€1.92 €0.03 (1.44%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALCJ.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 11, 2026

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Crossject SA (ALCJ.PA)

Based on 10 analysts giving stock ratings to Crossject SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Crossject SA. Stock Analysis ALCJ.PA

France Health Care Micro Cap Report: Q2, 2025

Crossject SA manufactures and markets needle free injection system. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The firm has industrial partnerships with Hirtenberger and Recipharm. The company provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.

Key Statistics of Crossject SA (ALCJ.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€1.91€1.94

Today's Open

€1.94

Volume

2510.00

P/E Ratio (TTM)

52 Week Range

€1.35€2.70

Market Cap

101.15M

Avg. Volume

69.95K

Dividend Yield

Financial Metrics & Statements of Crossject SA (ALCJ.PA)

FAQ's for Crossject SA (ALCJ.PA)

According to Musaffa’s Shariah screening methodology, Crossject SA (ALCJ.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.